These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25500624)

  • 41. JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia.
    Satriotomo I; Bowen KK; Vemuganti R
    J Neurochem; 2006 Sep; 98(5):1353-68. PubMed ID: 16923154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Main target of minimal hepatic encephalopathy: Morphophysiological, inflammatory and metabolic view.
    Arias N; Méndez M; Gómez-Lázaro E; Azpiroz A; Arias JL
    Physiol Behav; 2015 Oct; 149():247-54. PubMed ID: 26079568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nasal Colivelin treatment ameliorates memory impairment related to Alzheimer's disease.
    Yamada M; Chiba T; Sasabe J; Terashita K; Aiso S; Matsuoka M
    Neuropsychopharmacology; 2008 Jul; 33(8):2020-32. PubMed ID: 17928813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy.
    Felipo V; Urios A; Valero P; Sánchez M; Serra MA; Pareja I; Rodríguez F; Gimenez-Garzó C; Sanmartín J; Montoliu C
    Liver Int; 2013 Nov; 33(10):1478-89. PubMed ID: 23714168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. STAT3 inhibitor WP1066 as a novel therapeutic agent for bCCI neuropathic pain rats.
    Xue ZJ; Shen L; Wang ZY; Hui SY; Huang YG; Ma C
    Brain Res; 2014 Oct; 1583():79-88. PubMed ID: 25084036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Involvement of the Decrease of Astrocytic Wnt5a in the Cognitive Decline in Minimal Hepatic Encephalopathy.
    Ding S; Xu Z; Yang J; Liu L; Huang X; Wang X; Zhuge Q
    Mol Neurobiol; 2017 Dec; 54(10):7949-7963. PubMed ID: 27878554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective improvement by rifaximin of changes in the immunophenotype in patients who improve minimal hepatic encephalopathy.
    Mangas-Losada A; García-García R; Leone P; Ballester MP; Cabrera-Pastor A; Urios A; Gallego JJ; Martínez-Pretel JJ; Giménez-Garzó C; Revert F; Escudero-García D; Tosca J; Ríos MP; Montón C; Durbán L; Aparicio L; Montoliu C; Felipo V
    J Transl Med; 2019 Aug; 17(1):293. PubMed ID: 31462286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is cognitive impairment in cirrhotic patients due to increased peroxynitrite and oxidative stress?
    Gimenez-Garzó C; Urios A; Agustí A; González-López O; Escudero-García D; Escudero-Sanchis A; Serra MA; Giner-Durán R; Montoliu C; Felipo V
    Antioxid Redox Signal; 2015 Apr; 22(10):871-7. PubMed ID: 25557123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abnormal cortical synaptic plasticity in minimal hepatic encephalopathy.
    Golaszewski S; Langthaler PB; Schwenker K; Florea C; Christova M; Brigo F; Trinka E; Nardone R
    Brain Res Bull; 2016 Jul; 125():200-4. PubMed ID: 27475415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic effect of 7, 3'-dimethoxy hesperetin on adjuvant arthritis in rats through inhibiting JAK2-STAT3 signal pathway.
    Li R; Cai L; Ren DY; Xie XF; Hu CM; Li J
    Int Immunopharmacol; 2012 Oct; 14(2):157-63. PubMed ID: 22800927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Minimal hepatic encephalopathy: A review.
    Nardone R; Taylor AC; Höller Y; Brigo F; Lochner P; Trinka E
    Neurosci Res; 2016 Oct; 111():1-12. PubMed ID: 27153746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy.
    Gupta A; Dhiman RK; Kumari S; Rana S; Agarwal R; Duseja A; Chawla Y
    J Hepatol; 2010 Nov; 53(5):849-55. PubMed ID: 20675008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
    Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system.
    Rossner S; Schliebs R; Perez-Polo JR; Wiley RG; Bigl V
    J Neurosci Res; 1995 Jan; 40(1):31-43. PubMed ID: 7714924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients.
    Wuensch T; Ruether DF; Zöllner C; Mueller T; Jung T; Kaffarnik M; Kassner U; Schott E; Kiefer S; Pratschke J; Stockmann M; Jara M
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):456-463. PubMed ID: 28092641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits.
    Urios A; Mangas-Losada A; Gimenez-Garzó C; González-López O; Giner-Durán R; Serra MA; Noe E; Felipo V; Montoliu C
    Liver Int; 2017 Jul; 37(7):1013-1022. PubMed ID: 27988985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Minimal hepatic encephalopathy in children with chronic liver disease: Prevalence, pathogenesis and magnetic resonance-based diagnosis.
    Srivastava A; Chaturvedi S; Gupta RK; Malik R; Mathias A; Jagannathan NR; Jain S; Pandey CM; Yachha SK; Rathore RKS
    J Hepatol; 2017 Mar; 66(3):528-536. PubMed ID: 27815224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.